Skip to main content

Peer Review reports

From: LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients

Original Submission
4 Nov 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
27 Nov 2022 Reviewed Reviewer Report
16 Dec 2022 Reviewed Reviewer Report
29 Dec 2022 Author responded Author comments - Dengyong Zhang
Resubmission - Version 4
29 Dec 2022 Submitted Manuscript version 4
5 Jan 2023 Author responded Author comments - Dengyong Zhang
Resubmission - Version 5
5 Jan 2023 Submitted Manuscript version 5
7 Jan 2023 Author responded Author comments - Dengyong Zhang
Resubmission - Version 6
7 Jan 2023 Submitted Manuscript version 6
10 Jan 2023 Author responded Author comments - Dengyong Zhang
Resubmission - Version 7
10 Jan 2023 Submitted Manuscript version 7
13 Jan 2023 Reviewed Reviewer Report
14 Jan 2023 Reviewed Reviewer Report
27 Jan 2023 Author responded Author comments - Dengyong Zhang
Resubmission - Version 8
27 Jan 2023 Submitted Manuscript version 8
31 Jan 2023 Author responded Author comments - Dengyong Zhang
Resubmission - Version 9
31 Jan 2023 Submitted Manuscript version 9
2 Feb 2023 Author responded Author comments - Dengyong Zhang
Resubmission - Version 10
2 Feb 2023 Submitted Manuscript version 10
12 Feb 2023 Author responded Author comments - Dengyong Zhang
Resubmission - Version 11
12 Feb 2023 Submitted Manuscript version 11
Publishing
15 Feb 2023 Editorially accepted
17 Feb 2023 Article published 10.1186/s12859-023-05189-0

You can find further information about peer review here.

Back to article page